The M&A Hunter (@maandhunter): "Sana Biotechnology is UpToday at 3:15 PM Sana Biotechnology partners with Mayo Clinic to advance SC451 therapy. The collaboration aims for a Phase 1 clinical study this year, boosting investor confidence."

The app for independent voices

Sana Biotechnology is UpToday at 3:15 PM

Sana Biotechnology partners with Mayo Clinic to advance SC451 therapy. The collaboration aims for a Phase 1 clinical study this year, boosting investor confidence.

Apr 13

at

8:27 PM

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

The app for independent voices

Log in or sign up